GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Inventories, Raw Materials & Components

LTR Pharma (ASX:LTP) Inventories, Raw Materials & Components : A$0.00 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Inventories, Raw Materials & Components?

LTR Pharma's inventories, raw materials & components for the quarter that ended in Jun. 2023 was A$0.00 Mil.


LTR Pharma Inventories, Raw Materials & Components Historical Data

The historical data trend for LTR Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Inventories, Raw Materials & Components Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Inventories, Raw Materials & Components
- - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Inventories, Raw Materials & Components - - -

LTR Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines